# Luis Eduardo López-Cortés

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/luis-eduardo-lopez-cortes/

## Facts

| Field | Value |
| --- | --- |
| Citations | 4,515 |
| Field | Infective Endocarditis Diagnosis and Management |
| h-index | 32 |
| i10-index | 83 |
| Last Known Institution | Madrid Institute for Advanced Studies |
| OpenAlex ID | https://openalex.org/A5039185867 |
| ORCID iD | 0000-0002-9347-527X |
| Works | 169 |

## Researcher papers

- [Characteristics and predictors of death among 4035 consecutively hospitalized patients with COVID-19 in Spain](https://scholariq.org/papers/characteristics-and-predictors-of-death-among-4035-consecutively-hospitalized/)
- [Personalized bacteriophage therapy outcomes for 100 consecutive cases: a multicentre, multinational, retrospective observational study](https://scholariq.org/papers/personalized-bacteriophage-therapy-outcomes-for-100-consecutive-cases-a/)
- [Optimizing the Clinical Use of Vancomycin](https://scholariq.org/papers/optimizing-the-clinical-use-of-vancomycin/)
- [Impact of an Evidence-Based Bundle Intervention in the Quality-of-Care Management and Outcome of Staphylococcus aureus Bacteremia](https://scholariq.org/papers/impact-of-an-evidence-based-bundle-intervention-in-the-quality-of-care/)
- [Defining persistent Staphylococcus aureus bacteraemia: secondary analysis of a prospective cohort study](https://scholariq.org/papers/defining-persistent-staphylococcus-aureus-bacteraemia-secondary-analysis-of-a/)
- [Daptomycin Plus Fosfomycin Versus Daptomycin Alone for Methicillin-resistant <i>Staphylococcus aureus</i> Bacteremia and Endocarditis: A Randomized Clinical Trial](https://scholariq.org/papers/daptomycin-plus-fosfomycin-versus-daptomycin-alone-for-methicillin-resistant-i/)
- [Seven-versus 14-day course of antibiotics for the treatment of bloodstream infections by Enterobacterales: a randomized, controlled trial](https://scholariq.org/papers/seven-versus-14-day-course-of-antibiotics-for-the-treatment-of-bloodstream/)
- [DALBACEN cohort: dalbavancin as consolidation therapy in patients with endocarditis and/or bloodstream infection produced by gram-positive cocci](https://scholariq.org/papers/dalbacen-cohort-dalbavancin-as-consolidation-therapy-in-patients-with/)
- [Monotherapy versus combination therapy for sepsis due to multidrug-resistant Acinetobacter baumannii: analysis of a multicentre prospective cohort](https://scholariq.org/papers/monotherapy-versus-combination-therapy-for-sepsis-due-to-multidrug-resistant/)
- [Identification and validation of clinical phenotypes with prognostic implications in patients admitted to hospital with COVID-19: a multicentre cohort study](https://scholariq.org/papers/identification-and-validation-of-clinical-phenotypes-with-prognostic/)
- [Effectiveness of oral step-down therapy and early oral switch for bloodstream infections caused by Enterobacterales: A post hoc emulation trial of the SIMPLIFY trial](https://scholariq.org/papers/effectiveness-of-oral-step-down-therapy-and-early-oral-switch-for-bloodstream/)

## Researcher topics

- [Infective Endocarditis Diagnosis and Management](https://scholariq.org/topics/infective-endocarditis-diagnosis-and-management/)
- [Antimicrobial Resistance in Staphylococcus](https://scholariq.org/topics/antimicrobial-resistance-in-staphylococcus/)
- [Antibiotics Pharmacokinetics and Efficacy](https://scholariq.org/topics/antibiotics-pharmacokinetics-and-efficacy/)
- [Bacterial Identification and Susceptibility Testing](https://scholariq.org/topics/bacterial-identification-and-susceptibility-testing/)
- [Antibiotic Resistance in Bacteria](https://scholariq.org/topics/antibiotic-resistance-in-bacteria/)

## Researcher university

- [Madrid Institute for Advanced Studies](https://scholariq.org/institutions/madrid-institute-for-advanced-studies/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.